The launch of Cefepime-Enmetazobactam marks a significant milestone for India's pharmaceutical industry in fight against AMR
Dr. Reddy’s gets exclusive commercialization rights in the United States (U.S.) as well as semi-exclusive rights in Europe and United Kingdom (UK)
Collaboration to leverage AbbVie's psychiatry expertise and Gilgamesh's innovative research platform to develop next-generation neuroplastogens for the treatment of psychiatric disorders
The companies also plan to collaborate on several early pipeline projects, further technology exploration, and engineering of scalable manufacturing solutions across Novo Nordisk's portfolio
This partnership combines Tata Elxsi's design and technology expertise along with Dräger's expertise in medical and safety technology
Strategic multi-year research collaboration to identify novel targets with strong disease links and to accelerate clinical development
AbCellera will receive an upfront payment and is eligible to receive additional milestone payments
Through our research, we aim to ultimately provide new options for our customers to treat life-threatening infections in livestock
PathAI will exclusively work with Roche Tissue Diagnostics (RTD) to develop artificial intelligence (AI) digital pathology algorithms for RTD's companion diagnostics business.
Subscribe To Our Newsletter & Stay Updated
